Cancer Research: The Lessons to Learn from COVID-19
Bailey, C, Black, JRM, Swanton, C
2020UCL Discovery (University College London)27 citations
Abstract
Summary: The COVID-19 pandemic has caused widespread disruption of cancer clinical trials due to the restrictions on nonessential services and the reallocation of resources, and at the same time the urgent global effort toward discovering therapies that treat or prevent COVID-19 infection has led to shortening of traditional regulatory timelines. This experience should stimulate similar urgency in the way future cancer research is conducted.
Topics & Concepts
TimelineCoronavirus disease 2019 (COVID-19)PandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCancerClinical trialMedicineBusinessVirologyBioinformaticsBiologyGeographyDiseaseOutbreakInfectious disease (medical specialty)PathologyArchaeologyInternal medicineCOVID-19 and healthcare impactsPancreatic and Hepatic Oncology ResearchCOVID-19 Clinical Research Studies